Pegylated Interferon Alfa-2a from China
Pegylated recombinant interferon alfa-2a for chronic hepatitis C treatment, extending half-life for weekly dosing. An immunological product under HTS 3002.90.52.50 for therapeutic immune modulation. Biotechnologically modified cytokine.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Pegylation chemistry and activity data required
• Light-protected shipping for peg-interferon